We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00249093
First Posted: November 7, 2005
Last Update Posted: April 13, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
The norwegian association for heart and lung patients
Information provided by:
LHL Helse
  Purpose
The aim of the study is to evaluate effects of supplementary oxygen during exercise on dyspnoea and exercise tolerance in COPD-patients given long-time oxygen treatment

Condition Intervention
COPD Drug: oxygen

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single
Primary Purpose: Diagnostic

Resource links provided by NLM:


Further study details as provided by LHL Helse:

Primary Outcome Measures:
  • dyspnea
  • exercise tolerance

Estimated Enrollment: 20
Study Start Date: October 2005
Study Completion Date: April 2007
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD patients (male/female)given long-term oxygen treatment
  • Able to perform two separate walking tests

Exclusion Criteria:

  • Severe heart failure
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00249093


Locations
Norway
Glittreklinikken
Hakadal, Norway, 1485
Sponsors and Collaborators
LHL Helse
The norwegian association for heart and lung patients
Investigators
Principal Investigator: Morten S Ryg, dr philos LHL Helse
  More Information

ClinicalTrials.gov Identifier: NCT00249093     History of Changes
Other Study ID Numbers: G25-1
First Submitted: November 4, 2005
First Posted: November 7, 2005
Last Update Posted: April 13, 2007
Last Verified: April 2007


To Top